SSRI-related toxic serotonin syndrome: Improvement by discontinuation of treatment and propranolol

European Psychiatry

Volumn 12, Issue 6, 1997, Pages 321-323

  Dursun, S M ^a,b   Burke, J G ^a   Nielsen, F ^a   Mlynik Szmid, A ^a   Reveley, M A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Propranolol; Serotonin syndrome; SSRI; Toxic

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUOXETINE; PAROXETINE; PROPRANOLOL; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SULPIRIDE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DRUG INDUCED DISEASE; FEMALE; HUMAN; MALE; MENTAL DISEASE; NEUROTOXICITY; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SEROTONINERGIC TRANSMISSION; SYNDROME DELINEATION; TOXIC SEROTONIN SYNDROME;

EID: 0030843442     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(97)84795-5     Document Type: Article

References (7)

1. Dursun SM, Mathew VM, Reveley MA. Toxic serotontn syndrome after fluoxetine plus carbamazepine. Lancet 1993; 342:442-3
2. Dursun SM, Burke JG, Reveley MA. Toxic serotonin syndrome or extrapyramidal side-effects? Br J Psychiatry 1995;116:401-2
3. Green AR, Heal DJ. The effects of drugs on serotonin mediated behavioural models. In: Green AR, ed. Neuropharmacology of Serotonin. Oxford: Oxford University Press, 1985;326-65
4. Guze BH, Baxter LR. The serotonin syndrome: case responsive to propranolol. J Clin Psychopharmacol 1986;6: 119-20
5. Radomski JW, Dursun SM, Reveley MA. Toxic serotonin syndrome: an update and revised diagnostic criteria. J Psychopharm 1995;9(3 suppl):A21
6. 1A selective agonists. Eur J Pharmacol 1986;128:295-8
7. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148:705-13